Logue, James http://orcid.org/0000-0002-7410-9741
Johnson, Robert M. http://orcid.org/0000-0002-1976-7688
Patel, Nita
Zhou, Bin
Maciejewski, Sonia http://orcid.org/0000-0002-0202-1679
Foreman, Bryant
Zhou, Haixia
Portnoff, Alyse D.
Tian, Jing-Hui
Rehman, Asma
McGrath, Marisa E. http://orcid.org/0000-0002-7451-4958
Haupt, Robert E. http://orcid.org/0000-0001-8300-7184
Weston, Stuart M. http://orcid.org/0000-0001-9840-2953
Baracco, Lauren
Hammond, Holly
Guebre-Xabier, Mimi
Dillen, Carly
Madhangi, M.
Greene, Ann M. http://orcid.org/0000-0003-4769-9288
Massare, Michael J.
Glenn, Greg M.
Smith, Gale http://orcid.org/0000-0002-6482-6026
Frieman, Matthew B. http://orcid.org/0000-0003-0107-0775
Funding for this research was provided by:
Novavax, Inc
Article History
Received: 18 July 2022
Accepted: 12 December 2022
First Online: 28 February 2023
Competing interests
: N.P., B.Z., S.M., H.Z., A.D.P., J.-H.T., A.R., M.G.-X., M.M., A.M.G., M.J.M., G.M.G., and G.S. are employees of Novavax. J.L., R.M.J., M.E.M., R.E.H., S.M.W., H.H., and M.F. were supported in part by funds from Novavax. M.F. is on the Scientific Advisory Board of Aikido Pharma which has no role in this research. The remaining authors declare no competing interests.